Facebook Twitter LinkedIn Google Plus RSS

Derma Sciences acquires 7.3 percent of Comvita

By ,

Princeton-based advanced wound care company Derma Sciences announced Wednesday it has purchased 2.3 million newly issued common shares of New Zealand-based health and beauty company Comvita Limited for $7 million. The investment amounts to 7.3 percent of outstanding Comvita shares.

According to the announcement, the proceeds will support Comvita's apiary acquisition and harvest modernization strategy to ensure sufficient supply of medical grade honey to meet the growing demand for Derma Sciences' Medihoney product line.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy